MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastoma

Abstract

MYCN gene amplification is related to risk stratification. Therefore it is important to identify accurately the level of the MYCN gene as early as possible in neuroblastoma (NB); however, for patients with bone marrow (BM) metastasis who need chemotherapy before surgery, timely detection of the MYCN gene is not possible due to the unavailability of primary… (More)
DOI: 10.1186/s12935-017-0412-z

Topics

5 Figures and Tables

Cite this paper

@inproceedings{Yue2017MYCNAP, title={MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastoma}, author={Zhi-Xia Yue and Cheng Huang and Chao Gao and Tian-Yu Xing and Shu-guang Liu and Xing-Jun Li and Qian Zhao and Xi-si Wang and W. S. Zhao and Mei Jin and Xiao-Li Ma}, booktitle={Cancer Cell International}, year={2017} }